Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling

被引:19
作者
Kaufmann, GR
Zaunders, J
Murray, J
Kelleher, AD
Lewin, SR
Solomon, A
Smith, D
Cooper, DA
机构
[1] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[3] Univ New S Wales, Sch Math, Sydney, NSW 2031, Australia
[4] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 0DV, England
[5] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia
[6] Univ Melbourne, Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia
关键词
D O I
10.1089/08892220150217238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A major goal of antiretroviral HIV-1 therapy is the reversal of HIV-1-associated immunological dysfunction, However, the pathogenetic mechanisms involved and their significance are largely unknown. On the basis of the life cycle of naive, activated, and memory CD4(+) T cell subsets, a mathematical model of immune reconstitution was developed and applied to data for T cell subsets in individuals with acute or chronic HIV-1 infection receiving antiretroviral therapy. The final model that most accurately fitted the data, and resulted in realistic estimates for CD4(+) T cell turnover, considered three pathways of immune reconstitution for naive cells, including thymic production, peripheral expansion, and redistribution of naive cells from lymphoid tissue. The reconstitution of the memory compartment. was fitted through differentiation and expansion of naive cells and peripheral expansion of memory cells as well as redistribution of memory cells trapped in the lymphoid tissue. Estimated median half-lives for naive and memory CD4(+) T cells were 114 and 21 days, while total production rates were 9.1 x 10(7) and 2.4 x 10(9) cells/day, respectively. Peripheral expansion and thymic production contributed equally to the regeneration of naive cells, but peripheral expansion of memory cells was larger than production of these cells by differentiation of naive cells. A comparison of immune reconstitution in acute and chronic HIV-1 infection revealed that, after adjustment for age, the main difference was the more rapid release of a larger number of naive cells in treated acute HIV-1 infection. Thymic function and peripheral expansion rates, however, were similar in both cohorts.
引用
收藏
页码:147 / 159
页数:13
相关论文
共 34 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues [J].
Bucy, RP ;
Hockett, RD ;
Derdeyn, CA ;
Saag, MS ;
Squires, K ;
Sillers, M ;
Mitsuyasu, RT ;
Kilby, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (10) :1391-1398
[3]   CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen [J].
Bunce, C ;
Bell, EB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :767-776
[4]   T cell changes after combined nucleoside analogue therapy in HIV primary infection [J].
Carcelain, G ;
Blanc, C ;
Leibowitch, J ;
Mariot, P ;
Mathez, D ;
Schneider, V ;
Saimot, AG ;
Damond, F ;
Simon, F ;
Debré, P ;
Autran, B ;
Girard, PM .
AIDS, 1999, 13 (09) :1077-1081
[5]   Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine [J].
Collier, AC ;
Coombs, RW ;
Schoenfeld, DA ;
Bassett, RL ;
Timpone, J ;
Baruch, A ;
Jones, M ;
Facey, K ;
Whitacre, C ;
McAuliffe, VJ ;
Friedman, HM ;
Merigan, TC ;
Reichman, RC ;
Hooper, C ;
Corey, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1011-1017
[6]   Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV plus subjects [J].
De Paoli, P ;
Zanussi, S ;
Simonelli, C ;
Bortolin, MT ;
D'Andrea, M ;
Crepaldi, C ;
Talamini, R ;
Comar, M ;
Giacca, M ;
Tirelli, U .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2737-2743
[7]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695
[8]   Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study [J].
Egger, M ;
Hirschel, B ;
Francioli, P ;
Sudre, P ;
Wirz, M ;
Flepp, M ;
Rickenbach, M ;
Malinverni, R ;
Vernazza, P ;
Battegay, M ;
Bernasconi, E ;
Burgisser, P ;
Erb, P ;
Fierz, W ;
Grob, P ;
Gruninger, U ;
Jeannerod, L ;
Ledergerber, B ;
Luthy, R ;
Matter, L ;
Opravil, M ;
Paccaud, F ;
Perrin, L ;
Pichler, W ;
Piffaretti, GC ;
Rutschmann, O ;
Zanetti, G .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7117) :1194-1199
[9]   MODELING HIV-INFECTION OF CD4(+) T-CELL SUBPOPULATIONS [J].
ESSUNGER, P ;
PERELSON, AS .
JOURNAL OF THEORETICAL BIOLOGY, 1994, 170 (04) :367-391
[10]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733